As of June 30, 2026, Roche Holding Ltd carries a market capitalization of 36.59B, placing it among publicly traded companies globally. Its enterprise value stands at 62.68B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 36.59B |
| Enterprise Value | 62.68B |
As of June 30, 2026, Roche Holding Ltd has 106.69M shares outstanding.
| Shares Outstanding | 106.69M |
These figures are as of June 30, 2026.
| PB Ratio | 1.12 |
| P/TBV Ratio | 6.53 |
As of June 30, 2026, Roche Holding Ltd maintains a current ratio of 1.23, meaning it holds 1.2x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 1.23 |
| Quick Ratio | 0.34 |
| Debt / Equity | 86.62 |
As of the close on October 22, 2026, Roche Holding Ltd's stock has gained approximately 35.61% over the past 52 weeks. The 50-day moving average sits at 345.01, while the 200-day moving average is 313.17.
| 52-Week Price Change | 35.61% |
| 50-Day Moving Average | 345.01 |
| 200-Day Moving Average | 313.17 |
As of June 30, 2026, Roche Holding Ltd holds 9.73B in cash and equivalents against 31.81B in total debt, resulting in a net debt position of 26.36B. Total book value stands at 32.69B, with working capital of 6.59B providing operational flexibility.
| Cash & Cash Equivalents | 9.73B |
| Total Debt | 31.81B |
| Net Debt | 26.36B |
| Equity (Book Value) | 32.69B |
| Book Value Per Share | 306.43 |
| Working Capital | 6.59B |
Roche Holding Ltd's most recent stock split took place on May 4, 2001 with a 1:100 split ratio.
| Last Split Date | 5/4/2001 |
| Split Ratio | 1:100 |
Already premium?